Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ugur Coskun

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.
Basic & Clinical Pharmacology & Toxicology|February 1, 2006
Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patientsArzu Gunes, Ugur Coskun, Cem Boruban, et al.
International Immunopharmacology|April 14, 2009
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cellsMoses K Donkor, Elaine Lahue, Traci A Hoke, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2010
The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Suleyman Buyukberber, et al.
Japanese Journal of Clinical Oncology|March 4, 2015
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sitesOzge Gumusay, Mustafa Benekli, Ozgur Ekinci, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 9, 2008
Gemcitabine-induced acute coronary syndrome: a case reportBanu Ozturk, Gulten Tacoy, Ugur Coskun, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2012
Risk factors of nasopharyngeal carcinoma in Turkey-an epidemiological survey of the Anatolian Society of Medical OncologyFatma Paksoy Turkoz, Gokhan Celenkoglu, Gamze Gokoz Dogu, et al.
Medical Oncology (Northwood, London, England)|May 20, 2008
Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimensUgur Coskun, Ali Osman Kaya, Süleyman Buyukberber, et al.
Angiology|August 30, 2011
Admission hyperglycemia and TIMI frame count in primary percutaneous coronary interventionAhmet Yildiz, Alev Arat-Ozkan, Cuneyt Kocas, et al.
Breast Care (Basel, Switzerland)|April 10, 2014
Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) ExperienceBulent Cetin, Mustafa Benekli, Faysal Dane, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancersMeltem Baykara, Suleyman Buyukberber, Banu Ozturk, et al.
Basic & Clinical Pharmacology & Toxicology|February 1, 2006
Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patientsArzu Gunes, Ugur Coskun, Cem Boruban, et al.
International Immunopharmacology|April 14, 2009
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cellsMoses K Donkor, Elaine Lahue, Traci A Hoke, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2010
The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Suleyman Buyukberber, et al.
Japanese Journal of Clinical Oncology|March 4, 2015
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sitesOzge Gumusay, Mustafa Benekli, Ozgur Ekinci, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|December 9, 2008
Gemcitabine-induced acute coronary syndrome: a case reportBanu Ozturk, Gulten Tacoy, Ugur Coskun, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2012
Risk factors of nasopharyngeal carcinoma in Turkey-an epidemiological survey of the Anatolian Society of Medical OncologyFatma Paksoy Turkoz, Gokhan Celenkoglu, Gamze Gokoz Dogu, et al.
Medical Oncology (Northwood, London, England)|May 20, 2008
Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimensUgur Coskun, Ali Osman Kaya, Süleyman Buyukberber, et al.
Angiology|August 30, 2011
Admission hyperglycemia and TIMI frame count in primary percutaneous coronary interventionAhmet Yildiz, Alev Arat-Ozkan, Cuneyt Kocas, et al.
Breast Care (Basel, Switzerland)|April 10, 2014
Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) ExperienceBulent Cetin, Mustafa Benekli, Faysal Dane, et al.
Pageof 14